[1] 杨贤义,刘梅,柴林,等. 冻干重组人脑利钠肽联合左西孟旦对急性心力衰竭的疗效及对UA和BNP的影响[J]. 中国临床研究,2017,30(06):767-769. [2] Egom E E, Maher V, El Hiani Y. Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure[J]. Int J Card,2018,34(06):78-80. [3] Butler J, Vijayakumar S, Pitt B. Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists[J]. Eur J Heart Failure,2018,34(05):102-105. [4] Peterson EJ, Ng TMH, Patel KA, et al. Association of admission vs. nadir serum albumin concentration with short-term treatment outcomes in patients with acute heart failure[J]. J Int Med Res,2018,26(05):878-880. [5] 冯雪,吴岳,孟颖,等. 重组人脑利钠肽对重症心力衰竭患者的疗效和安全性:一项前瞻性多中心临床研究[J]. 中华危重病急救医学,2017,29(6):520-524. [6] 葛慧娟. 重组人脑利钠肽对于急性心肌梗死后老年心力衰竭患者疗效及预后的影响[J]. 中国老年学杂志,2016,36(3):602-604. [7] 殷泉忠,崔俊友,郑若龙,等. 不同给药方式对重组人脑利钠肽治疗慢性心力衰竭急性失代偿性重症患者的对比研究[J]. 中国医院药学杂志,2016,36(18):1571-1574. [8] 谭文婷,彭葳锐,唐芬,等. 重组人脑钠尿肽对心力衰竭大鼠心肌重构及缝隙链接蛋白43表达的影响[J]. 山东医药,2017,57(33):9-11.
2019, Vol. 36 
